0 Evaluaciones

ID

23842

Descripción

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Palabras clave

  1. 15/7/17 15/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

    Exploratory Biomarker Research Week 38

    EXPLORATORY BIOMARKER RESEARCH
    Descripción

    EXPLORATORY BIOMARKER RESEARCH

    Alias
    UMLS CUI-1
    C0005516
    Has the subject provided written consent for exploratory biomarker research?
    Descripción

    informed consent biomarker

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430
    UMLS CUI [1,2]
    C0005516
    Date of Assessment
    Descripción

    Date of Assessment

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C2985720
    Date of Assessment Skin Biopsy
    Descripción

    Date of Assessment Skin Biopsy

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C2985720
    UMLS CUI [1,2]
    C0150866
    Date of Assessment GI Biopsy
    Descripción

    Date of Assessment GI Biopsy

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C2985720
    UMLS CUI [1,2]
    C0005558
    UMLS CUI [1,3]
    C0017189

    Similar models

    Exploratory Biomarker Research Week 38

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    EXPLORATORY BIOMARKER RESEARCH
    C0005516 (UMLS CUI-1)
    informed consent biomarker
    Item
    Has the subject provided written consent for exploratory biomarker research?
    boolean
    C0021430 (UMLS CUI [1,1])
    C0005516 (UMLS CUI [1,2])
    Date of Assessment
    Item
    Date of Assessment
    date
    C2985720 (UMLS CUI [1])
    Date of Assessment Skin Biopsy
    Item
    Date of Assessment Skin Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0150866 (UMLS CUI [1,2])
    Date of Assessment GI Biopsy
    Item
    Date of Assessment GI Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0005558 (UMLS CUI [1,2])
    C0017189 (UMLS CUI [1,3])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial